Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6006
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vigo, Daniel | en_US |
dc.contributor.author | Haro, Josep Maria | en_US |
dc.contributor.author | Hwang, Irving | en_US |
dc.contributor.author | Aguilar-Gaxiola, Sergio | en_US |
dc.contributor.author | Alonso, Jordi | en_US |
dc.contributor.author | Borges, Guilherme | en_US |
dc.contributor.author | Bruffaerts, Ronny | en_US |
dc.contributor.author | Caldas-de-Almeida, Jose Miguel | en_US |
dc.contributor.author | de Girolamo, Giovanni | en_US |
dc.contributor.author | Florescu, Silvia | en_US |
dc.contributor.author | Gureje, Oye | en_US |
dc.contributor.author | Karam, Elie G. | en_US |
dc.contributor.author | Karam, Georges | en_US |
dc.contributor.author | Kovess-Masfety, Viviane | en_US |
dc.contributor.author | Lee, Sing | en_US |
dc.contributor.author | Navarro-Mateu, Fernando | en_US |
dc.contributor.author | Ojagbemi, Akin | en_US |
dc.contributor.author | Posada-Villa, Jose | en_US |
dc.contributor.author | Sampson, Nancy A | en_US |
dc.contributor.author | Scott, Kate | en_US |
dc.contributor.author | Stagnaro, Juan Carlos | en_US |
dc.contributor.author | Ten Have, Margreet | en_US |
dc.contributor.author | Viana, Maria Carmen | en_US |
dc.contributor.author | Wu, Chi-Shin | en_US |
dc.contributor.author | Chatterji, Somnath | en_US |
dc.contributor.author | Cuijpers, Pim | en_US |
dc.contributor.author | Thornicroft, Graham | en_US |
dc.contributor.author | Kessler, Ronald C | en_US |
dc.date.accessioned | 2022-08-16T06:25:28Z | - |
dc.date.available | 2022-08-16T06:25:28Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 00332917 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/6006 | - |
dc.description.abstract | Major depressive disorder (MDD) is a leading cause of morbidity and mortality. Shortfalls in treatment quantity and quality are well-established, but the specific gaps in pharmacotherapy and psychotherapy are poorly understood. This paper analyzes the gap in treatment coverage for MDD and identifies critical bottlenecks. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | National Library of Medicine | en_US |
dc.subject | Effective coverage | en_US |
dc.subject | Major depressive disorder | en_US |
dc.subject | Pharmacotherapy | en_US |
dc.subject | Psychotherapy | en_US |
dc.subject | Treatment | en_US |
dc.title | Toward measuring effective treatment coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1017/S0033291720003797 | - |
dc.identifier.pmid | 33077023 | - |
dc.identifier.scopus | 2-s2.0-85135499035 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85135499035 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.description.volume | 52 | en_US |
dc.description.issue | 10 | en_US |
dc.description.startpage | 1948 | en_US |
dc.description.endpage | 1958 | en_US |
dc.date.catalogued | 2022-08-16 | - |
dc.description.status | Published | en_US |
dc.identifier.openURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341444/ | en_US |
dc.relation.ispartoftext | Psychological Medicine | en_US |
dc.description.campus | SGH campus | en_US |
Appears in Collections: | Faculty of Medicine |
SCOPUSTM
Citations
16
checked on Nov 16, 2024
Record view(s)
61
checked on Nov 21, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.